Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pioglitazone with PegIFN/RBV in Chronic Hepatitis C with Insulin Resistance
NCT00927290Phase 3Terminated
- Sponsor
- ANRS
- Start
- Dec 2009
- Primary completion
- Jul 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of pioglitazone in hepatitis C (HCV), insulin resistance (IR), sponsored by ANRS. Started Dec 2009; status: terminated.
02
Drugs
pioglitazone
03
Conditions
hepatitis C (HCV)insulin resistance (IR)
Beyond the preview
Go deeper on NCT00927290.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00927290.